ReviewCancer2017
The emerging role of homologous recombination repair and PARP inhibitors in genitourinary malignancies.
Kalen J Rimar et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
38 papers cite it
this paperpooled ittrialcites it